Who owns FATE?
Institutional ownership of Fate Therapeutics Inc. from Form 13F, Q2 2026
155 institutional managers reported holding Fate Therapeutics Inc. (FATE) in Form 13F filings for Q2 2026, with 71,722,821 shares worth $194M. The largest reported holder was Redmile Group, LLC. Managers that filed both quarters cut a net 2,160,421 shares (-2.9%). 32 opened new positions and 30 sold out.
- Funds holding
- 155
- Value held
- $194M
- New / sold out
- 32 / 30
- Net shares, same filers
- -2.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of FATE
Share of 13F holdings is each fund's shares as a share of the 71,722,821 FATE shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Millennium Management LLC New+$6.6M
- T. Rowe Price Investment Management, Inc. New+$2.9M
- AQR Capital Management LLC Added+$2.3M
- Goldman Sachs Group Inc Added+$1.9M
- Qube Research & Technologies Ltd New+$1.6M
- Marshall Wace, LLP New+$1.3M
- Vanguard Portfolio Management LLC Added+$1.1M
- Point72 Asset Management, L.P. Added+$1.1M
- Jane Street Group, LLC Added+$1.0M
- Susquehanna Portfolio Strategies, LLC New+$913K
Biggest sellers in Q2 2026
- BlackRock, Inc. Trimmed-$7.5M
- State Street Corp Trimmed-$4.6M
- Geode Capital Management, LLC Trimmed-$3.4M
- UBS Group AG Trimmed-$3.3M
- Northern Trust Corp Trimmed-$1.5M
- Dimensional Fund Advisors LP Trimmed-$1.4M
- Tang Capital Management LLC Sold out-$1.4M
- Irenic Capital Management LP Sold out-$1.1M
- Monaco Asset Management SAM Sold out-$972K
- Bank of New York Mellon Corp Trimmed-$798K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $32.3M and sold $31.8M; 56 added and 35 trimmed.
Schedule 13D and 13G filings on FATE
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-05-09GOLDMAN SACHS GROUP INC SCHEDULE 13G filed by Fate Therapeutics Inc.Schedule 13G
Questions about FATE ownership
- Who owns FATE stock?
- 155 institutional investment managers reported FATE positions in their Form 13F filings for Q2 2026, holding 71,722,821 shares worth $194M in total. Redmile Group, LLC reported the largest position.
- Are funds buying or selling FATE?
- In Q2 2026, 32 managers opened new FATE positions, 56 added, 35 trimmed and 30 sold out. Managers that filed in both quarters sold a net 2,160,421 shares.
- How current is this FATE institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to FATE by CUSIP. Options are left out. FATE news and filings · FATE insider trades · Top funds